Companies Currently Raising

 
February 5 Presenting Companies

Organized by industry, scroll down for the full list of industries


Engineering the Future of Medicine. Creating Supernatural Peptides™ to access previously undruggable targets for a transformative positive impact on human health​.


AI and Regenerative Biology to design peptides that improve and extend lives​.


Developing novel therapeutics for unmet medical needs in metastatic castration-resistant prostate cancer, NASH liver fibrosis, & type 2 diabetes.



Improving patient outcomes in solid tumor cancer treatment.




The strength of steel. The soul of wood.


Fermentation-based platform providing a cost-competitive, environmentally friendly alternative to the traditional petroleum supply chain for sulfur ingredients.
Industry key:
Click on a Company’s name for contact information.

Organized by Industry

 
Want your company to be part of our exclusive listing?
Email us at srallison@opus8.com for more details!

 

For a full list of alumni, click here.

A social platform that’s transforming the way we interact online.

The Funding Platform for Every Family. Simple, One-Stop Funding. Every Age. Every Stage.

A next-generation AH-64 Apache flight simulator developed by DigiFlight.

Revolutionizing agriculture with advanced gene editing.



Revolutionizing plant breeding for a sustainable future.

Disrupting old elevator tech with vertical hyperloop for elegance and freedom in any multi-story home or office.

A clinical stage biopharmaceutical company developing a novel platform technology to treat multiple cancer types.

Innovative Solutions for Common Eye Conditions, Dry Eye, and Pink Eye.

Old-fashioned technology makes CPR unsafe. Compact Medical is on a mission to change that.

GenAssist develops biomaterials that regenerate muscle tissue.

A retinal biotech company improving eyesight in patients whose vision has been impaired by dry age-related macular degeneration.

The next generation of brain monitoring. Revolutionizing patient care through advanced neuromonitoring and AI.


Early Cancer Screening. Better Outcomes.

A disruptor of the $1.5T inflammation market with proven assets, bold IP, and a high-impact leadership team.

Revolutionizing endovascular solutions for dialysis access and peripheral artery disease (PAD).